Placental expression of syndecan 1 is diminished in preeclampsia

被引:28
作者
Jokimaa, VIS
Kujari, HP
Ekholm, EMK
Inki, PLK
Anttila, L
机构
[1] Univ Turku, Dept Obstet & Gynecol, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Pathol, FIN-20520 Turku, Finland
[3] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland
[4] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland
[5] Abo Akad Univ, Turku, Finland
关键词
Syndecan; 1; monoclonal antibody B-B4; placenta; preeclampsia; small for gestational age;
D O I
10.1067/mob.2000.107320
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Syndecan 1 is a cell surface heparan sulfate proteoglycan that binds growth factors and antithrombin III. The objective of this study was to examine whether placental expression of syndecan 1 in preeclampsia differs from that in normal pregnancy and whether gestational age and fetal growth affect syndecan 1 expression. STUDY DESIGN: An immunohistochemical analysis of 30 placentas of women with severe preeclampsia and 15 placentas of women without preeclampsia was performed with the monoclonal anti-syndecan 1 antibody B-B4. RESULTS: In 47% of preeclamptic placentas the immunoreactivity with antibody B-B4 was faint or absent, whereas 93% of the normal placentas exhibited strong immunoreactivity. The reduction in placental expression of syndecan 1 in preeclampsia was not associated with gestational age or impaired fetal growth. CONCLUSION: The expression of syndecan 1 on the chorionic villi is reduced in preeclampsia irrespective of gestational age or fetal growth.
引用
收藏
页码:1495 / 1498
页数:4
相关论文
共 18 条
[1]   Thrombin stimulates syndecan-1 promotor activity and expression of a form of syndecan-1 that binds antithrombin III in vascular smooth muscle cells [J].
CizmeciSmith, G ;
Carey, DJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2609-2616
[2]   ENHANCED THROMBIN GENERATION IN NORMAL AND HYPERTENSIVE PREGNANCY [J].
DEBOER, K ;
TENCATE, JW ;
STURK, A ;
BORM, JJJ ;
TREFFERS, PE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (01) :95-100
[3]   Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma [J].
Dhodapkar, MV ;
Kelly, T ;
Theus, A ;
Athota, AB ;
Barlogie, B ;
Sanderson, RD .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :368-371
[4]   Identification and location on syndecan-1 core protein of the epitopes of B-B2 and B-B4 monoclonal antibodies [J].
Dore, JM ;
Morard, F ;
Vita, N ;
Wijdenes, J .
FEBS LETTERS, 1998, 426 (01) :67-70
[5]  
ELENIUS K, 1992, J BIOL CHEM, V267, P6435
[6]  
Filla MS, 1998, J CELL PHYSIOL, V174, P310, DOI 10.1002/(SICI)1097-4652(199803)174:3<310::AID-JCP5>3.0.CO
[7]  
2-R
[8]   The syndecan family of proteoglycans - Novel receptors mediating internalization of atherogenic lipoproteins in vitro [J].
Fuki, IV ;
Kuhn, KM ;
Lomazov, IR ;
Rothman, VL ;
Tuszynski, GP ;
Iozzo, RV ;
Swenson, TL ;
Fisher, EA ;
Williams, KJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1611-1622
[9]  
Inki P, 1996, CYTOSKELETON, V3, P305
[10]   Expression of syndecan-1 in human placenta and decidua [J].
Jokimaa, V ;
Inki, P ;
Kujari, H ;
Hirvonen, O ;
Ekholm, E ;
Anttila, L .
PLACENTA, 1998, 19 (2-3) :157-163